SNV-1521
- Generic Name
- SNV-1521
SNV1521 in Participants with Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumor
- Interventions
- First Posted Date
- 2024-01-24
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Synnovation Therapeutics, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06220864
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
🇦🇺Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath